News - Merck Serono

Filter

Current filters:

Merck Serono

Popular Filters

19 to 43 of 69 results

Ablynx and Merck Serono expand collaboration on Nanobodies

Ablynx and Merck Serono expand collaboration on Nanobodies

26-09-2013

Ablynx and Merck Serono have expanded their collaboration on the co-discovery and co-development of Nanobodies.

AblynxBiotechnologyEuropeImmunologicalsMerck SeronoNeurologicalOncologyResearch

Improved overall survival prompts new Phase III study for Merck Serono

Improved overall survival prompts new Phase III study for Merck Serono

25-09-2013

Merck Serono will continue clinical development of its investigational MUC1 antigen-specific cancer immunotherapy…

BiotechnologyEuropeMerck SeronoOncologyResearch

ObsEva gets funding and makes deal with Merck Serono

30-08-2013

Geneva, Switzerland-based ObsEva says that it has closed a 32 million Swiss franc ($34.8 million) -A…

FinancialLicensingMerck KGaAMerck SeronoObsEvaPharmaceuticalWomen's Health

Merck KGaA 2nd-qtr sales slip, but EBITDA beats forecasts

06-08-2013

German health care and chemicals firm Merck KGaA (MRK: DE) reported second-quarter 2013 financial results,…

FinancialMerck KGaAMerck SeronoPharmaceutical

Merck Serono sets up new platform for cancer therapies innovation

26-06-2013

Merck Serono, the biopharmaceutical division of Germany's Merck KGaA (MRK: DE) says it has created a…

BiotechnologyImmunologicalsMerck KGaAMerck SeronoOncologyPharmaceuticalResearch

Merck Serono collaborates with China's BeiGene on second-generation BRAF Inhibitor

31-05-2013

Merck Serono, a division of Germany's Merck KGaA (MRK: DE), today (May 31) announced that it has signed…

BeiGeneBeiGene-283BiotechnologyLicensingMerck KGaAMerck SeronoOncologyPharmaceutical

Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux

23-05-2013

Australian drug developer Alchemia (ASX: ACL) and Merck Serono, a subsidiary of Germany's Merck KGaA…

AlchemiaBiotechnologyErbituxHA-IrinotecanMerck KGaAMerck SeronoOncologyPharmaceuticalResearch

Merck KGaA ups commitment to MS Ventures to 100 million euros

16-05-2013

Germany's Merck KGaA says that it will increase its commitment to its strategic corporate venture capital…

BiotechnologyFinancialMerck KGaAMerck SeronoResearch

Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC

16-05-2013

Merck Serono, a division of Germany's Merck KGaA (MRK: DE), announced detailed results from the randomized…

BiotechnologyL-BLP25Merck KGaAMerck SeronoOncologyPharmaceuticalResearchStimuvax

Merck Serono and Quintiles enter novel clinical development partnership

16-05-2013

Merck Serono, the biotech division of Germany's Merck KGaA (MRK: DE) and Quintiles (NYSE: Q) have announced…

BiotechnologyMerck KGaAMerck SeronoPharmaceuticalQuintilesResearch

Merck KGaA adjusted 1st-qtr earnings leap 19%, beating forecasts

14-05-2013

Shares of Germany's Merck KGaA out on 1.9% to 124.52 euros this morning (May 14), after the company reported…

FinancialMerck KGaAMerck SeronoPharmaceutical

AEterna Zentaris transfers Cetrotide rights to Merck KGaA

18-04-2013

Canada's AEterna Zentaris (TSX: AEZ) says that its German subsidiary has entered into binding agreements…

AEterna ZentarisCetrotideLicensingMerck KGaAMerck SeronoPharmaceuticalReproductive

Merck Serono's EPP funds EspeRare Foundation, which will reposition rimeporide

15-04-2013

Merck Serono, the biotech unit of Germany's Merck KGaA (MRK: DE) has announced the launch of the EspeRare…

BiotechnologyEspeRare FoundationFinancialMerck KGaAMerck SeronoPharmaceuticalRare diseasesResearchrimeporide

Columbia Labs extends ex-US Crinone accord with Merck Serono into 2020

09-04-2013

USA-based Columbia Laboratories (Nasdaq: CBRX) has amended its license and supply agreement with Merck…

Columbia LaboratoriesCrinoneLicensingMerck KGaAMerck SeronoPharmaceuticalReproductive

AstraZeneca acquires AlphaCore; Merck Serono links with BioMed X

03-04-2013

In line with its stated policy of targeted acquisitions, Anglo-Swedish drug major AstraZeneca (LSE: AZN)…

AlphaCore PharmaAstraZenecaBiotechnologyCardio-vascularMerck KGaAMerck SeronoMergers & AcquisitionsMetabolicsPharmaceuticalResearch

Merck Serono collaborates with Nordic Bioscience for sprifermin in osteoarthritis

18-03-2013

German drug and chemical major Merck KGaA (MRK: DE) says its Merck Serono division has entered into a…

Anti-Arthritics/RheumaticsMerck KGaAMerck SeronoNordic BiosciencePharmaceuticalResearchsprifermin

Merck KGaA posts strong sales and earnings growth for 2012

07-03-2013

Germany's Merck KGaA today reported financial results for 2012 showing 8.7% growth in total revenues…

BiotechnologyFinancialMerck KGaAMerck SeronoPharmaceutical

Merck KGaA's glioblastoma candidate cilengitide fails in Ph III study

25-02-2013

German drug major Merck KGaA (MRK: DE) revealed this morning that the Phase III CENTRIC trial of the…

BiotechnologycilengitideMerck KGaAMerck SeronoOncologyPharmaceuticalResearch

Merck Serono to in-license Opexa's MS drug candidate Tcelna

06-02-2013

USA-based Opexa Therapeutics (Nasdaq: OPXA) has entered into an agreement with Merck Serono, a division…

BiotechnologyLicensingMerck KGaAMerck SeronoNeurologicalOpexa TherapeuticsPharmaceuticalTcelna

Merck Serono initiation of TH-302 Ph III trial triggers $30 million milestone for Threshold

29-01-2013

Merck Serono, the pharma division of Germany's Merck KGaA (MRK: DE), has initiated the global Phase III…

FinancialMerck KGaAMerck SeronoOncologyPharmaceuticalResearchTH-302Threshold Pharmaceuticals

Merck Serono NSCLC vaccine candidate fails to meet primary endpoint in Ph III

20-12-2012

Merck Serono, a division of Germany's Merck KGaA (MRK: DE), Darmstadt, says that the Phase III START…

L-BLP25Merck KGaAMerck SeronoOncologyOncothyreonPharmaceuticalResearchStimuvaxVaccines

Merck Serono collaborates with Neopharma for production in UAE

04-12-2012

Merck Serono, a division of Germany's Merck KGaA (MRK: DE), Germany, and Unite Arab Emirates drug manufacturer…

DiabetesEuthyroxGlucophageGlucophage XRMerck KGaAMerck SeronoNeopharmaPharmaceuticalProductionRest of the WorldWomen's Health

19 to 43 of 69 results

Company Spotlight

Fibrotech

Fibrotech

Back to top